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Introduction 
 
Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are both used as cross-
sectional imaging methods for the detection of a variety of brain lesions in humans and 
animals. Each method has specific advantages and disadvantages to detect selected lesion 
characteristics.  
CT VERSUS MRI 
CT 
X-rays 
widespread available 
less expensive 
short imaging times 
transverse plane (+ reconstructions) 
suitable for patients with implants 
 
ionated contrast (more adverse effects) 
excellent resolution of bony detail 
beam hardening artefacts (dense bone) 
MRI 
magnetic field 
not widely available 
expensive 
long imaging times 
different planes 
not suitable for patients with metallic 
implants 
gadolinium based contrast 
excellent soft-tissue contrast 
motion artefacts 
 
 
When is CT modality of choice? 
 
MRI is the preferred imaging modality for intracranial tumors due to the better soft-tissue 
contrast and the sensitivity to detect increased amounts of water which is the case in most 
pathological conditions. MRI is more accurate in defining the extent and morphology of 
tumors than is CT. However, neither of these techniques provides absolute specifity. Most 
intracranial tumors can be visualized on CT. Caudal fossa lesion can be missed on CT due to 
beam hardening artefacts. Intravenous contrast agents should be used for both CT and MRI 
studies if a tumor is suspected.  
 
Inflammatory brain disease can effect brain parenchyma (encephalitis), meningen 
(meningitis) or both (meningoencephalitis) and can be subdivided into infectious 
inflammatory and non-infectious inflammatory disorders. Lesions can manifest as multifocal 
or focal diffuse lesions. Some diseases have signal attenuation similar to surrounding tissue 
and little or no contrastuptake  and can be missed on CT. MRI sequences such as FLAIR 
(Fluid Attenuated Inversion Recovery) suppress cerebrospinal fluid signals and have a higher 
sensitivity for subtle changes than the normal spin echo sequences and CT. Hence MRI is in 
these cases also the modality of choice.  
 
Congenital and developmental anomalies can be detected on CT.  Ventricular size in dogs or 
cats with hydorcephalus, the size of an intra-arachnoid cyst, cerebellar herniations can be 
diagnosed with CT. But also in these cases MRI gives a more accurate soft tissue contrast and 
underlying causes will be picked up earlier on MRI. CT can be used for follow-up assessment 
of changes in the ventricular size. 
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Metabolic, nutritional, toxic en degenerative disease give in many cases subtle changes or 
normal appereances on CT. Bilateral symmetric hypodense lesions, ventriculomegaly, 
enlarged sulci can be an indication for these kind of diseases. MRI is overall more sensitive in 
these cases.   
 
In cerebrovascular disease CT is the modality of choice in acute hemorrhagic strokes. In 
edema and lacunar infarctation MRI is more sensitive. 
 
CT is the primary procedure for evaluating intracranial complications after acute skull 
trauma in the first 24 hours. Acess to monitoring of the unstable patiënts is easy and  scan 
times are relatively short compared to MRI. CT images are very sensitive for acute 
hemorrhage and intracranial gas. Excellent bony detail makes CT the best modality for 
assessing fractures of the skull base and calvaria. 
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Comparison study 
 
CT and MRI studies were compared to look at the agreement between CT and MRI  for the 
detection of suspected intracranial lesions in dogs and cats. Over a period of 2 years, 58 
patients with a suspected brain lesion underwent both CT and MRI studies of the brain. The 
following parameters were evaluated: presence of an intracranial lesion, pattern of occurrence 
(solitary or multiple), lesion localization (lobe or region), aspect of margins (well-defined or 
ill-defined), pre- and post-contrast size of the lesions presence of mass effect, and presence 
and pattern of enhancement (homogeneous, heterogeneous or ring enhancement). In 38 
patients a lesion was detected on CT and/or MRI. On 30 patients the lesion was detected both 
on CT and MRI. Seven lesions detected on MRI were not detected on CT. These lesions 
included 3 suspected infarctations, 2 patients with only edema and 2 patients with suspected 
diffuse inflammatory disease. These lesions were missed on CT because MRI is more 
sensitive for subtle soft tissue changes and different sequences can be used to differentiate 
normal brain parenchyma from pathological conditions. The lesion that was seen on CT and 
not on MRI was a suspected diffuse multifocal lesion. Delayed contrast enhancement could be 
the cause of this missed lesion. Only 26 of the 30 lesions were identically classified as solitary 
or multifocal on both imaging modalities. In view of the clinical importance, the degree of 
disagreement between CT and MRI for detection of intracranial lesions should be regarded as 
clinically relevant. Once a lesion is detected, however, CT and MRI may be considered 
concordant for the most diagnostically important imaging characteristics (ie mass effect and 
contrast agent enhancement). The lesion dimensions may direct treatment, and the poor 
agreement between CT and MRI may thus be clinically relevant. Altough substantial 
agreement between modalities was achieved for the localization of lesions to specific 
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anatomic brain for most regions, the degree of agreement was highly variable especially for 
lesions in the brainstem and the pyriform lobe, and this could influence diagnosis. Although 
this study had limitations (no confirmed diagnosis, single slice CT-scan, 4mm slices and 
small sample size) we can overall conclude and suggest  that MRI is the preferred technique 
to document intracranial pathology. However, the data also indicate that CT may be regarded 
a valuable alternative to detect intracranial lesions and selected lesion characteristics when 
MRI is unavailable.  
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